The Department of Drug Administration (DDA) has decided to approve ‘COVISHIELD’ COVID-19 vaccine for emergency use in Nepal. DDA provided the conditional permission for emergency authorisation of COVISHEILD vaccine against COVID-19. COVISHEILD is the first COVID-19 vaccine approved for use in Nepal.
Detail notice;
Related
- What is COVAX? Why we need COVAX? What COVAX offers?
- Principles for sharing COVID-19 Vaccine doses with COVAX
- Vaccines development process & Clinical trials
- World Immunization Week 2020 #VaccinesWork for All
⚡ Looking for expert analysis, policy briefs, and high-level reviews on Nepal's health sector?
We are now offering premium subscription services to deliver timely, evidence-backed policy briefs, comprehensive technical reviews, and strategic analysis straight to your inbox. Tap into specialized consultant expertise and stay ahead on Nepal's emerging health strategies.
👉 [Contact Us]
Do you have a website? Looking for the best hosting provider? Here’s a discount code.
Latest Public Health Jobs
Latest Posts
- PEN-Plus Orientation Manual for Mid-Level Health Care Workers
- National Health Training Strategy 2082
- Simulation Accreditation Manual for Clinical Training Sites
- Training Quality Improvement Tools 2026
- Nepal Netra Jyoti Sangh Receives Prestigious WHO Regional Award for Public Health Champion
Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated
Comments are closed.